CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +21,250 | 71,892 | ||
| 2025-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +21,250 | 93,142 | ||
| 2025-01-02 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award · Option to purchase common stock | +42,500 | 42,500 | ||
| 2025-01-02 | Bair Teresa Brophy Chief Legal Officer | Grant or award | +46,250 | 115,229 | ||
| 2025-01-02 | Bair Teresa Brophy Chief Legal Officer | Grant or award · Option to purchase common stock | +92,500 | 92,500 | ||
| 2025-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award | +46,250 | 61,250 | ||
| 2025-01-02 | Powl Brian T. Chief Commercial Officer | Grant or award · Option to purchase common stock | +92,500 | 92,500 | ||
| 2025-01-02 | FORD KATHLEEN Chief Operating Officer | Grant or award · Option to purchase common stock | +185,000 | 185,000 | ||
| 2025-01-02 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +625,000 | 625,000 | ||
| 2024-11-18 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −526 | $16.03 | $8K | 23,184 |
| 2024-09-13 | VASCONCELLES MICHAEL Director | Grant or award · Option to purchase common stock | +52,000 | 52,000 | ||
| 2024-09-13 | VASCONCELLES MICHAEL Director | Grant or award · Option to purchase common stock | +17,333 | 17,333 | ||
| 2024-06-05 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2024-06-05 | Szela Mary T Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2024-06-05 | Parks Diane L. Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2024-06-05 | SCHAFER CAROL Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2024-06-05 | Malley Thomas Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2024-06-05 | Collins Helen Louise Director | Grant or award · Option to purchase common stock | +26,000 | 26,000 | ||
| 2024-05-20 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −2,615 | $22.15 | $58K | 68,979 |
| 2024-01-30 | DALE STEPHEN Chief Medical Officer | Sale | −4,825 | $21.55 | $104K | 38,817 |
Page 7 of 9 · 164 trades